The North America Image-guided Therapy Systems Market would witness market growth of 5.0% CAGR during the forecast period (2022-2028).
IGT has grown significantly in relevance in the healthcare industry and ought to be regarded as an essential part of the great majority of treatment plans that cover almost all medical specialties. The accuracy and safety of the procedures carried out based on imaging the appropriate target is the main benefits of IGT. Compliance with legal regulations is required when executing IGT because of the highly demanding technological requirements, specialized training, and abilities.
This field will be beneficial to the fields of radiation oncology, surgery, nuclear medicine, and radiology. However, imaging specializations will need to be heavily involved in the establishment of the standards in IGT since in this quickly developing field, agreements on the best practices, parametric imaging results, measurements, analysis, and presentations are crucial. This may be especially true for IGT. Radiologists ought to be in charge of defining and upholding the legal requirements for non-radiologists use of radiological imaging.
One of the factors driving the growth of the Image-guided Therapy Systems market is the increased healthcare spending by the governments of developed countries like Canada. Additionally, the presence of several important market players in this area would hasten the expansion of the local market. It is predicted that the growing number of studies being conducted to create technologically improved and effective processes will fuel the growth of the regional market. To guarantee that inhabitants have access to the greatest healthcare facilities, the government has drafted several healthcare and reimbursement policies. This has led to a rise in the demand for micro CT in this area.
The US market dominated the North America Image-guided Therapy Systems Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,409.8 Million by 2028. The Canada market is poised to grow at a CAGR of 7.4% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 6.5% during (2022 - 2028).
Based on Application, the market is segmented into Cardiac Surgery, Urology, Neurosurgery, Gastroenterology, Orthopedic Surgery, Oncology Surgery and Others. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Research & Academic Institutions. Based on Product, the market is segmented into Endoscopes, Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scanners, Ultrasound Systems, X-ray Fluoroscopy and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Image-guided Therapy Systems Market is Predict to reach $5.5 Billion by 2028, at a CAGR of 5.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., Medtronic PLC, Siemens Healthineers AG (Siemens AG), Analogic Corporation, General Electric (GE) Co. (GE Healthcare), Brainlab AG, Olympus Corporation, and Stryker Corporation.
By Application
By End-Use
By Product
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
